DOCSLIB.ORG

Endocrinological Assessment of Toxic Effects on the Male Reproductive System in Rats Treated with 5-Fluorouracil for 2 Or 4 Weeks

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Endocrinological Assessment of Toxic Effects on the Male Reproductive System in Rats Treated with 5-Fluorouracil for 2 Or 4 Weeks The Journal of Toxicological Sciences, 49 Vol.27, No.1, 49-56, 2002 ENDOCRINOLOGICAL ASSESSMENT OF TOXIC EFFECTS ON THE MALE REPRODUCTIVE SYSTEM IN RATS TREATED WITH 5-FLUOROURACIL FOR 2 OR 4 WEEKS Setsuko TAKIZAWA and Ikuo HORII Department of Preclinical Science, Nippon Roche K. K., Research Center, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan (Received October 25, 2001; Accepted December 11, 2001) ABSTRACT — Endocrinological assessment of male reproductive toxicity was carried out in SD-Slc male rats treated with 5-FU (0, 20, 30 mg/kg/day) orally for 2-week or 4-week term. Serum hormone levels including GnRH, FSH, LH, prolactin, total and free testosterone, inhibin B, pro-alpha C, and activin A were determined as well as histopathological examination of the reproductive organs. The 5-FU treated groups showed histopathological changes in the testis such as degeneration of seminifer- ous epithelium. An obvious decrease in serum testosterone level was observed with a reduced organ weight of the seminal vesicle and prostate. However, no significant changes were noted in serum LH or FSH levels, nor in the morphological examination of the Leydig cells. Decreased serum levels were noted in activin A and prolactin. An increased serum level was noted in GnRH and pro-alpha C whose synthesis is regulated by FSH. Serum inhibin B levels showed a tendency toward decreasing with morphological change (vac- uolation) in Sertoli cells. These results indicated that male reproductive toxicity induced by 5-FU would be augmented by decreased serum prolactin and testosterone levels as well as a decreased func- tion of Sertoli cell, in addition to the direct cytotoxic effects on germ cells. It is suggested that these endocrinological changes related to male reproductive toxicities can be detected even in the 2-week- treated study. KEY WORDS: 5-FU,Rat,Testis,Testosterone,Prolactin,InhibinB INTRODUCTION toxicity of germ cells during spermatogenesis through antimetabolic activity of 5-FU mediated by an inhibi- Themalereproductivetoxicityof5-fluorouracil tion of thymidylate synthetase and an erroneous incor- (5-FU; antimetabolites) has been investigated in exper- porationintoRNAandDNA(O’Dwyeret al., 1987; imental animals (D’Souza and Narayana, 2001; Horii Pinedo and Peters, 1988; Schuetz et al., 1984; et al., 1985; Miyazaki et al., 1974; Russell and Russell, Waxman et al., 1990). 1991), and some morphological changes such as In addition to the morphological assessment of defects of spermatogenesis, atrophy of seminiferous male reproductive organs such as the testis and seminal epithelium, and decreased organ weight of the male vesicle, endocrinological evaluation gives useful infor- reproductive organs (seminal vesicle and prostate) mation for clarifying the toxicological mechanism were demonstrated. It is known that male reproductive through an endocrinological axis. Male reproductive toxicity of 5-FU is primarily caused by the direct cyto- toxicities would often be managed by the feedback Correspondence: Setsuko TAKIZAWA Vol. 27 No. 1 50 S. TAKIZAWA et al. mechanism of toxicologically responsible hormones in in the 2-week study. All rats in the 2- and 4-week tox- terms of toxicological intensity and property. Although icity studies were killed at 10 weeks old. The 0-4W endocrinological assessment of 5-FU was performed group was used as control in both studies. in female rat (Kuo et al., 1975), male reproductive tox- icity has not been evaluated endocrinologically. Dose selection rationale In this study, endocrinological assessment was In a 4-week repeated oral toxicity study of 5-FU carried out in rats treated with a low dose of 5-FU for 4 in Wistar rats, mortality was observed at 42 mg/kg/day weeks or low and high doses of 5-FU for 2 weeks, and and above, and an inhibition of body weight gain and changes in endocrinological parameters were clarified. hematological changes were noted at 30 mg/kg/day A possible toxicological mechanism through the endo- and above (Miyazaki et al., 1974). A 5-week repeated crinological axis was also investigated, as well as a oral toxicity study of 5-FU in SD rats showed a mortal- correlation of dose and treatment period. ity at 40 mg/kg/day (Horii et al., 1985). An inhibited body weight gain, hematological changes, and a MATERIALS AND METHODS decreased organ weight of reproductive organs were noted at 20 mg/kg/day. Based on these results, 20 mg/ Animals kg/day in the 4-week study and 20 or 30 mg/kg/day in SD-Slc male rats (12 males at 5 weeks old for the the 2-week study were chosen as the dose levels that 4-week study and 12 males at 7 weeks old for the 2- must induce some reproductive toxicity without severe week study) were obtained from Nippon SLC Corpora- inhibition of body weight gain and hematological tion (Shizuoka, Japan). After 1 week of acclimatiza- changes. tion, 10 healthy animals (5 rats/group) were selected for the experiment. They were housed individually in Experimental testing design metal cages in a room with a temperature of 22 ± 2°C, On the day next to final dosing (13:00-15:00), a relative humidity of 55 ± 10%, and a 12-hr light/dark animals were euthanised by carbon dioxide, and blood cycle (light: 7:00-19:00). Standard diet CRF-1 samples were collected from the heart. Serum samples (Charles River Japan, Ltd.) and tap water were given were stored at –40°C until endocrinological analysis. ad libitum. The animals were classed according to their Male reproductive organs were removed, weighed, and body weights and allocated randomly to groups using a fixed in Bouin’s solution (testes and epididymides) or computerized randomization program. 15% buffered formalin (seminal vesicle and prostate). HE staining specimens were histopathologically evalu- Test article and dosing ated by microscopy. 5-Fluorouracil (5-FU) was provided by Nippon RocheK.K.5-FUwasdissolvedindistilledwater,and Measurement of endocrinological parameters administered to male rats by oral intubation for 28 or Serum follicle stimulating hormone (FSH) and 14 days at a dose level of 0, 20, or 30 mg/kg/day with luteinizing hormone (LH) levels were determined by an administration volume of 10 ml/kg body weight. radio immunoassay (RIA) kit supplied from NHPP, Volumes for administration were calculated based on NIDDK (Bethesda, MD, USA). Prolactin (Rat prolac- the most recent body weight. tin (rPRL) [125I] assay system, Amersham Life Science, Buckinghamshire, UK), total testosterone (DPC total Animal experiment - dosing design testosterone kit, Diagnostic Products Corporation, Los Two-week and 4-week treatment periods were Angeles, USA), and free testosterone (DPC free tes- chosen to investigate endocrinological properties and tosterone kit, Diagnostic Products Corporation) levels if the changes observed in a 4-week study can be were analyzed by RIA. Gonadotrophin Releasing Hor- detected even in a 2-week study that is needed essen- mone (GnRH)(Endokit Red TM LHRH, CYT Immune tially to support human clinical trials. In a 4-week Sciences, Inc., MD, USA), inhibin B (Inhibin B assay repeated toxicity study, animals were treated with 5- kit, Serotec, Oxford, UK), Activin A (Activin-A assay FU at a dose level of 0 (0-4W group) or 20 mg/kg/day kit, Serotec), and pro-alpha C (Inhibin pro-alpha C (20-4W group). In a 2-week repeated toxicity study, assay kit, Serotec) were measured by enzyme-linked dose levels of 20 (20-2W group) and 30 mg/kg/day immunosorbent assay (ELISA). All analyses were per- (30-2W group) were chosen. The age at the start of formed in duplicate. dosing was 6 weeks in the 4-week study, and 8 weeks Vol. 27 No. 1 51 Endocrinological assessment of male reproductive toxicity induced by 5-FU. Statistical analysis B level. Two rats which showed vacuolation of Sertoli Differences between the control and drug-treated cells had the lowest level of Inhibin B. Activin A was groups were evaluated by Student’s t-test (Gad and distinctly decreased in all the drug-treated groups (Fig. Weil, 1982). p<0.05 was considered statistically sig- 2). nificant. DISCUSSION RESULTS In this study, histopathological examination Body weight revealed degeneration of seminiferous epithelium and The 20-4W group showed an inhibition of body vacuolation of Sertoli cells in the testis, and desqua- weight gain, and the 20-2W and 30-2W groups demon- mated cell debris in the ducts of epididymis in rats strated a decrease of body weight during the experi- given 5-FU. 5-FU caused no histopathological changes mental period. in the seminal vesicle or prostate in spite of a decreased relative organ weight. Similar lesions in the male Organ weight of reproductive system reproductive system, referring to reduced organ Regarding absolute organ weight, 5-FU caused a weight, defects of spermatogenesis, and so on, were significant decrease in weight of the testes, epidid- noted in previous studies on 5-FU (Miyazaki et al., ymides, seminal vesicle, and prostate in correspon- 1974; Horii et al., 1985; Russell and Russell, 1991; dence to a decrease in body weight. On the other hand, D’Souza and Narayana, 2001). abrupt body weight loss led to feigned results in rela- It has been known that the pharmacological tive organ weight: the testis and epididymis. In con- effects of 5-FU were mediated through the following trast, the relative organ weights of the seminal vesicle mechanisms for cytotoxicity: (1) Inhibition of and prostate were decreased in the drug-treated groups thymidylate synthetase (mutilation of deoxyuridylic (Fig. 1). acid and catalysis in the synthesis of thymidylic acid) resulting in a decrease of thymidine and inhibition of Histopathological examination of reproductive sys- DNA synthesis (Waxman et al., 1990); (2) Direct tem incorporation into nuclear RNA, resulting in process- Histopathological examination revealed degener- ing errors during formation of cytoplasmic RNA ation of seminiferous epithelium in testis and desqua- (Pinendo and Peters, 1988) and (3) Incorporation of mated cell debris in ducts of epididymis in the drug- residues into DNA, resulting in DNA damage treated groups.
Load more

Recommended publications
  • Activin-A As an Intraovarian Modulator: Actions, Localization, and Regulation of the Intact Dimer in Human Ovarian Cells
    Activin-A as an intraovarian modulator: actions, localization, and regulation of the intact dimer in human ovarian cells. J Rabinovici, … , R Schwall, R B Jaffe J Clin Invest. 1992;89(5):1528-1536. https://doi.org/10.1172/JCI115745. Research Article The actions, localization, and regulation of activin in the human ovary are unknown. Therefore, the aims of this study were (a) to define the effects of recombinant activin-A and its structural homologue, inhibin-A, on mitogenesis and steroidogenesis (progesterone secretion and aromatase activity) in human preovulatory follicular cells; (b) to localize the activin-A dimer in the human ovary by immunohistochemistry; and (c) to examine regulation of intracellular activin-A production in cultured human follicular cells. In addition to stimulating mitogenic activity, activin-A causes a dose- and time-dependent inhibition of basal and gonadotropin-stimulated progesterone secretion and aromatase activity in human luteinizing follicular cells on day 2 and day 4 of culture. Inhibin-A exerts no effects on mitogenesis, basal or gonadotropin- stimulated progesterone secretion and aromatase activity, and does not alter effects observed with activin-A alone. Immunostaining for dimeric activin-A occurs in granulosa and cumulus cells of human ovarian follicles and in granulosa- lutein cells of the human corpus luteum. cAMP, and to a lesser degree human chorionic gonadotropin and follicle- stimulating hormone, but not inhibin-A, activin-A, or phorbol 12-myristate 13-acetate, increased the immunostaining for activin-A in cultured granulosa cells. These results indicate that activin-A may function as an autocrine or paracrine regulator of follicular function in the human ovary.
    [Show full text]
  • Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells'
    ICANCERRESEARCH56. I 155-I 163. March I. 19961 Inhibitory Effects of Activin on the Growth and Morphogenesis of Primary and Transformed Mammary Epithelial Cells' Qiu Yan Liu, Birunthi Niranjan, Peter Gomes, Jennifer J. Gomm, Derek Davies, R. Charles Coombes, and Lakjaya Buluwela2 Departments of Medical Oncology (Q. Y. L, P. G.. J. J. G., R. C. C., L B.J and Biochemistry (Q. Y. L. L B.J. Charing Cross and Westminster Medical School, Fuiham Palace Road. London W6 8RF; Division of Cell Biology and Experimental Pathology. Institute of Cancer Research, 15 Cotswald Rood, Sutton. Surrey SM2 SNG (B. NJ; and FACS Analysis Laboratory. imperial Cancer Research Fund, Lincoln ‘sInnFields. London WC2A 3PX (D. DI, United Kingdom ABSTRACT logical activities of activin. Indeed, two types of activin receptors have aLready been identified in the mouse (28) and several forms in Activin Is a member of the transforming growth factor fi superfamily, Xenopus (29, 30). The sequences of the Act-RI! (3 1), the TGF-@ type which is known to have activities Involved In regulating differentiation II receptor (32), the TGF-f3 type I receptor (33), and various activin and development. By using reverse transcrlption.PCR analysis on immu noafflnity.purlfied human breast cells, we have found that activin IJa and receptor-like genes (34) have been described. The comparison of these activin type II receptor are expressed by myoepithelial cells, whereas no sequences shows that they belong to a newly defined family of expression was detected In other breast cell types. In examining 15 breast membrane-bound, ligand-activated serine-threonine kinases (35).
    [Show full text]
  • Production and Purification of Recombinant Human Inhibin and Activin
    199 Production and purification of recombinant human inhibin and activin S A Pangas1 and T K Woodruff1,2 1Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois 60208, USA 2Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611, USA (Requests for offprints should be addressed to T K Woodruff; Email: [email protected]) Abstract Inhibin and activin are protein hormones with diverse Conditioned cell media can be purified through column physiological roles including the regulation of pituitary chromatography resulting in dimeric mature 32–34 kDa FSH secretion. Like other members of the transforming inhibin A and 28 kDa activin A. The purified recom- growth factor- gene family, they undergo processing binant proteins maintain their biological activity as from larger precursor molecules as well as assembly into measured by traditional in vitro assays including the regu- functional dimers. Isolation of inhibin and activin from lation of FSH in rat anterior pituitary cultures and the natural sources can only produce limited quantities of regulation of promoter activity of the activin-responsive bioactive protein. To purify large-scale quantities of promoter p3TP-luc in tissue culture cells. These proteins recombinant human inhibin and activin, we have utilized will be valuable for future analysis of inhibin and activin stably transfected cell lines in self-contained bioreactors to function and have been distributed to the US National produce protein. These cells produce approximately Hormone and Peptide Program. 200 µg/ml per day total recombinant human inhibin. Journal of Endocrinology (2002) 172, 199–210 Introduction residues (Dubois et al. 2001, Leitlein et al. 2001). The subtilisin-like proprotein covertases also cleave other Inhibin is a gonadal peptide originally isolated from ovarian TGF- family members such as Mullerian-inhibiting follicular fluid (Ling et al.
    [Show full text]
  • A Study of Serum Levels of Inhibin a and B, Pro Alpha-C and Activin a in Women with Ovulatory Disturbances Before and After Stimulation with Gnrh
    European Journal of Endocrinology (2000) 143 77±84 ISSN 0804-4643 CLINICAL STUDY Inverse correlation between baseline inhibin B and FSH after stimulation with GnRH: a study of serum levels of inhibin A and B, pro alpha-C and activin A in women with ovulatory disturbances before and after stimulation with GnRH Fritz W Casper, Rudolf J Seufert1 and Kunhard Pollow Department of Experimental Endocrinology and 1Department of Obstetrics and Gynecology, Johannes Gutenberg University Mainz, D-55101 Mainz, Germany (Correspondence should be addressed to F W Casper, Department of Experimental Endocrinology, Langenbeckstrasse 1, D-55101 Mainz, Germany; Email: [email protected]) Abstract Objective: Interest has focused recently on the in¯uences of the polypeptide factors inhibin and activin on the selective regulation of the pituitary secretion of gonadotropins. Design: Measurement of the concentrations of inhibin-related proteins in relation to the changes in pituitary gonadotropin (FSH, LH) parameters, after GnRH stimulation with a bolus injection of 100 mg gonadorelin, in 19 women with ovulatory disturbances. Methods: Serum levels of inhibin A and B, activin A, and pro alpha-C were measured using sensitive ELISA kits. Results: Within 60 min after GnRH stimulation, FSH values doubled from 5 to 10 mU/ml (P < 0.001). LH increased 12-fold from 2 to 24 mU/ml (P < 0.001). Activin A showed a signi®cant decrease from 0.47 to 0.36 ng/ml (P < 0.001), whereas pro alpha-C increased from 127 to 156 pg/ml (P 0.039). The median inhibin A concentration did not show a signi®cant change between baseline and the 60 min value, whereas inhibin B was characterized by a minor, but not signi®cant, increase in the median from 168 to 179 pg/ml (P 0.408).
    [Show full text]
  • Novel Approaches to Positively Impact the Early Life Physiology, Endocrinology, and Productivity of Bulls
    Novel Approaches to Positively Impact the Early Life Physiology, Endocrinology, and Productivity of Bulls DISSERTATION Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Bo R. Harstine, M.S. Graduate Program in Animal Sciences The Ohio State University 2016 Dissertation Committee: Dr. Michael L. Day, Advisor Mel DeJarnette Dr. Christopher Premanandan Dr. Gustavo Schuenemann Dr. Joseph Ottobre Copyrighted by Bo Randall Harstine 2016 ABSTRACT Changes to sire selection, such as the utilization of genomic evaluations, have created a desire to collect semen from superior sires as early as possible. Therefore, a series of experiments was performed in order to determine whether a novel exogenous FSH treatment hastened puberty and positively impacted postpubertal semen production in bulls. In the first experiment, angus-cross bulls received either 30 mg NIH-FSH-P1 in a 2% hyaluronic acid solution (FSH-HA, n =11) or saline (control, n = 11) every 3.5 days from 59 to 167.5 days of age. Blood was collected every 7 days to determine testosterone concentrations and at 59, 84, 94, 130, and 169 days of age to determine activin A concentrations. FSH concentrations were determined from blood collected preceding treatment every 3.5 days, as well as during three intensive collections commencing at 66, 108, and 157 days of age. Castration was performed at 170 days of age to examine testis weight, volume, diameter of seminiferous tubules, and the number of Sertoli cells per tubule cross section. Concentrations of FSH did not differ from 59 to 91 days of age, but became greater (P < 0.05) in FSH-HA than control bulls from 94 to 167.5 days.
    [Show full text]
  • Activin-A Stimulates Hypothalamic Gonadotropin-Releasing Hormone Release by the Explanted Male Rat Hypothalamus: Interaction with Inhibin and Androgens
    269 Activin-A stimulates hypothalamic gonadotropin-releasing hormone release by the explanted male rat hypothalamus: interaction with inhibin and androgens A E Calogero, N Burrello, A M Ossino, P Polosa and R D’Agata Division of Andrology, Department of Internal Medicine, University of Catania, 95123 Catania, Italy (Requests for offprints should be addressed to A E Calogero, Istituto di Medicina Interna e Specialita` Internistiche, Ospedale Garibaldi, Piazza S.M. di Gesu`, 95123 Catania, Italy) Abstract The presence of activins in those hypothalamic regions had no effect on GnRH output. As previously shown, containing gonadotropin-releasing hormone (GnRH)- testosterone (1 nmol/l) and dihydrotestosterone (DHT, secreting neurons suggests that these peptides may regulate 0·1 nmol/l) suppressed basal GnRH release, but only the reproductive function modulating not only pituitary testosterone was able to inhibit the release of GnRH FSH release and biosynthesis, but also hypothalamic stimulated by activin-A. Since DHT is a non-aromatizable GnRH release. The purpose of this study was to evaluate androgen, we evaluated whether the inhibitory effect of the effects of activin-A, a homodimer of inhibin âA testosterone was due to its in vitro conversion into 17â- subunit, on hypothalamic GnRH release in vitro and, estradiol. The addition of 4-hydroxyandrostenedione, a because of their well known antithetical effects, to evalu- steroidal aromatase inhibitor, did not influence the sup- ate its interaction with inhibin. In addition, since andro- pressive effect of testosterone on GnRH release stimulated gens modulate the release of GnRH from male rat by activin-A. hypothalami, we thought it of interest to study the possible In conclusion, activin-A stimulated hypothalamic interplay between these steroids and activin on GnRH GnRH release in vitro and this effect was abolished by release.
    [Show full text]
  • Immunoh Foil Istatin Istochemical Localiza in Human Tissues Tion of Activin A
    Endocrine Journal 1996, 43(4), 375-385 immunoh istochemical Localiza tion of Activin A and Foil istatin in Human Tissues MIcHIKO WADA, YASUMI SHINTANI, MASAAKI KOSAKA, TosHIAKI SANO*, KAzuo HIZAWA*, AND SHIRO SAITO First Department of Internal Medicine and *First Department of Pathology, School of Medicine, The University of Tokushima, Tokushima 770, Japan Abstract. We immunohistochemically investigated the localization of activin A and follistatin in various human tissues with specific antibodies to recombinant human (rh-) activin A and rh-follistatin. Specific immunostaining of activin A was detected in Leydig and Sertoli cells of the testis. In the ovary, granulosa cells of mature follicle and luteal cells of the corpus luteum stained for activin A. Immunoreactive activin A was present in somatotrophs of the pituitary gland and insulin-positive B cells of the pancreatic islets. Immunoreactivity for activin A was also found in thyroid follicular cells, adrenocortical cells, neuronal cells of the cerebrum and monocytoid cells in the bone marrow. Follistatin, an activin-binding protein, was immunostained in the same tissues as activin A. These findings indicated that activin A and follistatin are widely distributed in human tissues, suggesting that activin plays important roles as a common regulator in various tissues under the control of co-existing follistatin. Key words: Activin , Follistatin, Inhibin, Immunohistochemistry (Endocrine Journal 43: 375-385,1996) ACTIVIN and inhibin are both dimeric proteins logical activities. It regulates erythropoiesis [6], originally isolated from porcine follicular fluid and promotes nerve cell survival [7], inhibits neural able to influence FSH release from the pituitary differentiation [8], induces embryonic mesoderm [1-3].
    [Show full text]
  • Inhibin and Activin Modulate the Release of Gonadotropin-Releasing Hormone, Human Chorionic Gonadotropin, and Progesterone From
    Proc. Nati. Acad. Sci. USA Vol. 86, pp. 5114-5117, July 1989 Medical Sciences Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured human placental cells (foliculostatin/follicle-stimulating hormone-releasing protein/follitropin/foliicle-stimulating hormone) FELICE PETRAGLIA*, JOAN VAUGHAN, AND WYLIE VALEt Clayton Foundation Laboratories for Peptide Biology, The Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037 Communicated by C. H. Sawyer, March 20, 1989 (receivedfor review September 23, 1988) ABSTRACT Although it is clear that human chorionic cotropin], supports the hypothesis that placental hormono- gonadotropin (hCG) and progesterone play fundamental roles genesis may be regulated in part by locally produced peptides in pregnancy, the regulation of placental production of these (13-22). hormones remains to be defined. Recent evidence suggests that A recent report (11) showed that the addition of inhibin the human placenta expresses proteins related to inhibin (afi antiserum increased hCG production in primary human pla- subunits) or activin (8P subunits). Inhibin and activin (follicle- cental cultures, suggesting that endogenous inhibin might stimulating hormone-releasing protein) possess opposing ac- tonically inhibit secretion of the placental gonadotropin. To tivities in several biological systems including pituitary follicle- evaluate the possible roles of inhibin-related proteins in the stimulating hormone (follitropin) secretion, erythroid differ- regulation of placental hormones more directly, we have entiation, and gonadal sex-steroid production. The actions of investigated the effects-ofinhibin and activin on the secretion purified inhibin and activin on hormonogenesis by primary ofGnRH, hCG, and progesterone by cultured placental cells. cultures of human placental cells were studied.
    [Show full text]
  • Activins and Inhibins: Roles in Development, Physiology, and Disease
    Downloaded from http://cshperspectives.cshlp.org/ on October 5, 2021 - Published by Cold Spring Harbor Laboratory Press Activins and Inhibins: Roles in Development, Physiology, and Disease Maria Namwanje1 and Chester W. Brown1,2,3 1Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas 77030 2Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030 3Texas Children’s Hospital, Houston, Texas 77030 Correspondence: [email protected] Since their original discovery as regulators of follicle-stimulating hormone (FSH) secretion and erythropoiesis, the TGF-b family members activin and inhibin have been shown to participate in a variety of biological processes, from the earliest stages of embryonic devel- opment to highly specialized functions in terminally differentiated cells and tissues. Herein, we present the history, structures, signaling mechanisms, regulation, and biological process- es in which activins and inhibins participate, including several recently discovered biolog- ical activities and functional antagonists. The potential therapeutic relevance of these advances is also discussed. INTRODUCTION, HISTORY AND which the activins and inhibins participate, rep- NOMENCLATURE resenting some of the most fascinating aspects of TGF-b family biology. We will also incorporate he activins and inhibins are among the 33 new biological activities that have been recently Tmembers of the TGF-b family and were first discovered, the potential clinical relevance of described as regulators of follicle-stimulating
    [Show full text]
  • Activin Receptors in Gonadotrope Cells: New Tricks for Old Dogs
    Activin receptors in gonadotrope cells: new tricks for old dogs By Carlis Rejón G. Department of Pharmacology and Therapeutics McGill University Montréal, Canada June, 2012 A thesis submitted to McGill in partial fulfilment of the requirements of the degree of Doctor of philosophy Copyright ©Carlis Rejón G., 2012 Dedication I have had many role models during my life: Mother Teresa, a little woman with a huge spirit, who created a worldwide institution destined to assist the poorest people, regardless of their beliefs. Marie Curie an example of perseverance and dedication towards science, she was the first person to win two Nobel prizes (in Physics and Chemistry). However, my closest source of inspiration comes from a strong woman whom, with a lot of effort was able to raise four children alone. She taught me to be perseverant, honest and humble in the pursuit of my dreams. I dedicate this manuscript to her, Carmen Gonzalez, my mom. 2 Abstract Activins are members of the transforming growth factor β (TGFβ) superfamily. Though originally identified as stimulators of pituitary follicle-stimulating hormone (FSH) synthesis and secretion, they also play diverse biological roles, ranging from control of cellular differentiation to regulation of immune responses. To exert their biological effects, activins and other TGFβ family members signal through a heterotetrameric complex composed of two type I (also called activin receptor-like kinases or ALKs) and two type II transmembrane serine/threonine kinase receptors. Within the superfamily, ligands greatly outnumber receptors, hence multiple ligands share receptors and individual ligands can bind various receptors. For instance, activins bind to type II receptors ACVR2 and ACVR2B, leading to recruitment, phosphorylation, and activation of type I receptors (predominantly ALK4 for activins), which in turn phosphorylate downstream effectors.
    [Show full text]
  • Activin and Inhibin in the Human Adrenal Gland. Regulation and Differential Effects in Fetal and Adult Cells
    Activin and inhibin in the human adrenal gland. Regulation and differential effects in fetal and adult cells. S J Spencer, … , P C Goldsmith, R B Jaffe J Clin Invest. 1992;90(1):142-149. https://doi.org/10.1172/JCI115827. Research Article Recent experimental data have revealed that activins and inhibins exert pivotal effects on development. As part of our studies on growth and differentiation of the human fetal adrenal gland, we examined the subunit localization, as well as the mitogenic and steroidogenic actions of activin and inhibin in human fetal and adult adrenals. All three activin and inhibin subunit proteins (alpha, beta A, and beta B) were detected in the fetal and adult adrenal cortex. Immunoreactive activin-A dimer was demonstrated in midgestation fetal and neonatal adrenals. ACTH1-24-stimulated fetal adrenal cell expression of alpha and beta A subunit messenger RNA. In addition, ACTH elicited a rise in levels of immunoreactive alpha subunit secreted by fetal and adult adrenal cells. Human recombinant activin-A inhibited mitogenesis and enhanced ACTH-stimulated cortisol secretion by cultured fetal zone cells, but not definitive zone or adult adrenal cells. Recombinant inhibin-A had no apparent mitogenic or steroidogenic effects. Thus, activin selectively suppressed fetal zone proliferation and enhanced the ACTH-induced shift in the cortisol/dehydroepiandrosterone sulfate ratio of fetal zone steroid production. These data indicate that activin-A may be an autocrine or paracrine factor regulated by ACTH, involved in modulating growth and differentiated function of the human fetal adrenal gland. Find the latest version: https://jci.me/115827/pdf Activin and Inhibin in the Human Adrenal Gland Regulation and Differential Effects in Fetal and Adult Cells Susan J.
    [Show full text]
  • CHARACTERIZATION of the IMMUNE RESPONSE to ANTI-MÜLLERIAN HORMONE JUSTIN M. JOHNSON Bachelor of Science in Biology University O
    CHARACTERIZATION OF THE IMMUNE RESPONSE TO ANTI-MÜLLERIAN HORMONE JUSTIN M. JOHNSON Bachelor of Science in Biology University of Akron December 1994 Submitted in partial fulfillment of requirements for the degree DOCTOR OF PHILOSOPHY IN REGULATORY BIOLOGY WITH SPECIALIZATION IN CELLULAR AND MOLECULAR MEDICINE at the CLEVELAND STATE UNIVERSITY December 2020 Copyright 2020 Justin M. Johnson We hereby approve this dissertation For Justin M. Johnson Candidate for the Doctor of Regulatory Biology degree with specialization in Cellular and Molecular Medicine for the Department of Biological, Geological, and Environmental Sciences And CLEVELAND STATE UNIVERSITY'S College of Graduate Studies by __________________________________________________Date:_____________ Dr. Vincent K. Tuohy, Department of Inflammation and Immunity, Cleveland Clinic Major Advisor __________________________________________________Date:_____________ Dr. Anton Komar, Department of BGES, Cleveland State University Advisory Committee Member __________________________________________________Date:_____________ Dr. Xiaoxia Li, Department of Inflammation and Immunity, Cleveland Clinic Advisory Committee Member __________________________________________________Date:_____________ Dr. William Baldwin, Department of Inflammation and Immunity, Cleveland Clinic Advisory Committee Member __________________________________________________Date:_____________ Dr. Barsanjit Mazumder, Department of BGES, Cleveland State University Internal Examiner __________________________________________________Date:_____________ Dr. Anna Valujskikh, Department of Inflammation and Immunity, Cleveland Clinic External Examiner DEDICATION To Miss Mencl, who taught me how to put on my jacket all by myself. And to my Mom, for believing me when I pretended that I couldn’t. To Mr. Taylor, who put the idea of “Doc” in my head. And to Dr. Tuohy who made it happen. To my colleagues who encouraged me. And to my committee that inspired me. To my family and friends who motivated me to push on. And to my students who knew that I could do it.
    [Show full text]